HouseH.R. 9632119th Congress

To better coordinate Federal efforts to utilize advance technologies, such as AI, to improve diagnoses, treatments, cures, and prevention strategies for pediatric cancer, and for other purposes.

Full Text

Official text as published. Use Ctrl+F / Cmd+F to search within the document.

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9632 Introduced in House (IH)]

<DOC>

119th CONGRESS
  2d Session
                                H. R. 9632

 To better coordinate Federal efforts to utilize advance technologies, 
  such as AI, to improve diagnoses, treatments, cures, and prevention 
        strategies for pediatric cancer, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              July 9, 2026

   Mr. McCaul (for himself, Mr. Bera, and Mr. Kelly of Pennsylvania) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
 To better coordinate Federal efforts to utilize advance technologies, 
  such as AI, to improve diagnoses, treatments, cures, and prevention 
        strategies for pediatric cancer, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Accelerating Innovation (AI) for 
Kids with Cancer Act''.

SEC. 2. HARNESSING UNITED STATES AI INNOVATION TO TREAT AND CURE 
              PEDIATRIC CANCER.

    (a) In General.--The President, in consultation with the Secretary 
of Health and Human Services (in this section referred to as the 
``Secretary''), shall appoint an individual or entity to serve as the 
coordinator of Federal efforts to utilize advance technologies, such as 
AI, to improve diagnoses, treatments, cures, and prevention strategies 
for pediatric cancer. Such individual or entity shall be known as the 
Coordinator of AI Innovation (in this section referred to as the 
``Coordinator''). The Coordinator shall serve as a member of the 
Domestic Policy Council.
    (b) Identification of CCDI Opportunities.--In carrying out 
subsection (a), the Coordinator shall identify opportunities to 
accelerate the progress of AI-driven solutions at the Childhood Cancer 
Data Initiative (in this section referred to as the ``CCDI''), 
including--
            (1) by improving clinical trial design and access through 
        incorporating AI approaches;
            (2) by making data platforms and tools available as part of 
        the CCDI Data Ecosystem;
            (3) by improving data infrastructure through consolidating 
        data from multiple sources for AI-ready analysis and through 
        utilizing AI to better select participants for clinical trials;
            (4) by enhancing data analysis through integration with AI 
        tools--
                    (A) to improve predictive modeling of patient 
                response, disease progression, and treatment toxicity; 
                and
                    (B) to turn multi-omics data and imaging data into 
                novel diagnostic, prognostic, and therapeutic 
                biomarkers; and
            (5) by improving clinical trial design, access, and 
        outcomes for patients by incorporating multimodal data and 
        using AI approaches.
    (c) Improving Data Sharing and Empowering Patients.--
            (1) Integration of ai innovation into current work on 
        interoperability.--The Secretary shall work to ensure that AI 
        innovation is appropriately integrated into current work on 
        interoperability to maximize the potential for electronic 
        health records and claims data to inform private sector and 
        academic research and clinical trial design, while ensuring 
        that individuals (or authorized representatives) control their 
        health information.
            (2) Interoperability standards for patient data to be used 
        with ai.--The Secretary shall work to finalize interoperability 
        standards for patient data to be used with AI that--
                    (A) appropriately account for structured and 
                unstructured data; and
                    (B) enable safe and privacy-compliant exchanges of 
                data.
    (d) Report.--Not later than 180 days after the date of the 
enactment of this Act, the Secretary shall submit to the appropriate 
committees of Congress a report on the implementation of this section.
    (e) Definitions.--In this section:
            (1) Artificial intelligence; ai.--The terms ``artificial 
        intelligence'' and ``AI'' have the meaning given the term 
        ``artificial intelligence'' in section 5002 of the National 
        Artificial Intelligence Initiative of 2020 (15 U.S.C. 9401).
            (2) Appropriate committees of congress.--The term 
        ``appropriate committees of Congress'' means--
                    (A) the Committee on Energy and Commerce of the 
                House of Representatives;
                    (B) the Committee on Science, Space, and Technology 
                of the House of Representatives;
                    (C) the Committee on Health, Education, Labor, and 
                Pensions of the Senate; and
                    (D) the Committee on Commerce, Science, and 
                Transportation of the Senate.
    (f) Authorization of Appropriations.--
            (1) In general.--There are authorized to be appropriated to 
        carry out this section such funds as may be necessary for each 
        of fiscal years 2027 through 2031.
            (2) CCDI.--In addition to amounts made available to carry 
        out this section under paragraph (1) for a fiscal year, there 
        is authorized to be appropriated to carry out subsection (b), 
        $100,000,000 for each of fiscal years 2027 through 2031.
                                 <all>